SEC Form 4 · accession 0001645627-17-000035
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 13, 2017
Accepted (ET)
Apr 18, 2017 · 12:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.058 | A | 20,166,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0593 | A | 20,167,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0589 | A | 20,168,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.059 | A | 20,169,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0589 | A | 20,170,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0586 | A | 20,171,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.059 | A | 20,172,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.05 | A | 20,173,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.05 | A | 20,174,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.05 | A | 20,175,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0499 | A | 20,176,849 | D |
Table II — derivative securities
No Table II lines on this filing.